loading
前日終値:
$61.45
開ける:
$61.74
24時間の取引高:
846.49K
Relative Volume:
1.26
時価総額:
$4.29B
収益:
$136.86M
当期純損益:
$-168.69M
株価収益率:
-22.32
EPS:
-2.81
ネットキャッシュフロー:
$-113.49M
1週間 パフォーマンス:
+1.19%
1か月 パフォーマンス:
+6.00%
6か月 パフォーマンス:
+12.84%
1年 パフォーマンス:
+56.32%
1日の値動き範囲:
Value
$61.00
$62.92
1週間の範囲:
Value
$60.80
$64.00
52週間の値動き範囲:
Value
$39.46
$69.89

Rhythm Pharmaceuticals Inc Stock (RYTM) Company Profile

Name
名前
Rhythm Pharmaceuticals Inc
Name
セクター
Healthcare (1174)
Name
電話
857-264-4280
Name
住所
222 BERKELEY STREET, BOSTON, MA
Name
職員
283
Name
Twitter
@rhythmpharma
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
RYTM's Discussions on Twitter

RYTM を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RYTM
Rhythm Pharmaceuticals Inc
62.73 4.29B 136.86M -168.69M -113.49M -2.81
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Rhythm Pharmaceuticals Inc Stock (RYTM) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-07 アップグレード BofA Securities Neutral → Buy
2025-03-05 再開されました Stifel Buy
2025-01-02 開始されました Jefferies Buy
2024-12-20 開始されました Oppenheimer Outperform
2024-10-21 開始されました Guggenheim Buy
2024-09-18 開始されました H.C. Wainwright Buy
2024-09-17 開始されました JMP Securities Mkt Outperform
2024-05-08 ダウングレード BofA Securities Buy → Neutral
2023-12-19 アップグレード Morgan Stanley Equal-Weight → Overweight
2023-08-01 アップグレード BofA Securities Neutral → Buy
2023-01-18 再開されました Canaccord Genuity Buy
2022-08-08 アップグレード Goldman Neutral → Buy
2022-08-05 アップグレード BofA Securities Underperform → Neutral
2022-06-17 繰り返されました Needham Buy
2022-03-02 再開されました Stifel Buy
2022-02-17 アップグレード Ladenburg Thalmann Neutral → Buy
2021-12-08 開始されました Wells Fargo Overweight
2021-11-19 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-09-14 再開されました Goldman Neutral
2021-08-04 ダウングレード BofA Securities Neutral → Underperform
2021-08-04 ダウングレード Ladenburg Thalmann Buy → Neutral
2020-11-30 ダウングレード BofA Securities Buy → Neutral
2020-01-08 開始されました Goldman Sell
2019-07-12 アップグレード Stifel Hold → Buy
2019-07-08 開始されました Canaccord Genuity Buy
2019-03-13 開始されました Ladenburg Thalmann Buy
2018-09-07 再開されました Morgan Stanley Overweight
2018-06-25 繰り返されました Needham Buy
2018-06-15 繰り返されました Needham Buy
2017-10-30 開始されました BofA/Merrill Buy
2017-10-30 開始されました Needham Buy
すべてを表示

Rhythm Pharmaceuticals Inc (RYTM) 最新ニュース

pulisher
Jun 18, 2025

GAMMA Investing LLC Grows Stock Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

Jun 18, 2025
pulisher
Jun 18, 2025

SG Americas Securities LLC Buys Shares of 19,667 Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

Jun 18, 2025
pulisher
Jun 18, 2025

22,192 Shares in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Bought by Assenagon Asset Management S.A. - Defense World

Jun 18, 2025
pulisher
Jun 16, 2025

(RYTM) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 15, 2025

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives $76.62 Average Target Price from Brokerages - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Acquired by Rhumbline Advisers - Defense World

Jun 14, 2025
pulisher
Jun 09, 2025

Rhythm Pharma stock soars to all-time high of $69.7 By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Rhythm Pharmaceuticals at Goldman Sachs Conference: Strategic Focus on Rare Diseases - Investing.com Nigeria

Jun 09, 2025
pulisher
Jun 09, 2025

Rhythm Pharma stock soars to all-time high of $69.7 - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

Transcript : Rhythm Pharmaceuticals, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08 - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

Rhythm Pharmaceuticals (RYTM) Gets Price Target Upgrade by Stifel Amid Obesity Drug Optimism - MSN

Jun 09, 2025
pulisher
Jun 07, 2025

Millennium Management LLC Sells 21,718 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Jefferies Maintains Buy Rating on Rhythm Pharmaceuticals (RYTM), Sets $80 Price Target - Yahoo Finance

Jun 05, 2025
pulisher
Jun 05, 2025

Jefferies maintains buy rating on Rhythm Pharmaceuticals stock By Investing.com - Investing.com UK

Jun 05, 2025
pulisher
Jun 05, 2025

Citizens JMP maintains $84 target on Rhythm Pharmaceuticals stock By Investing.com - Investing.com UK

Jun 05, 2025
pulisher
Jun 04, 2025

Rhythm Pharmaceuticals at Jefferies Conference: Strategic Pipeline Insights By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

Rhythm Pharmaceuticals at Jefferies Conference: Strategic Pipeline Insights - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

(RYTM) Proactive Strategies - news.stocktradersdaily.com

Jun 04, 2025
pulisher
May 30, 2025

Stifel Nicolaus Issues Positive Forecast for Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price - Defense World

May 30, 2025
pulisher
May 29, 2025

Rhythm Pharmaceuticals (RYTM) Target Price Raised by Stifel Anal - GuruFocus

May 29, 2025
pulisher
May 29, 2025

12 Analysts Assess Rhythm Pharmaceuticals: What You Need To Know - Benzinga

May 29, 2025
pulisher
May 29, 2025

Rhythm Pharmaceuticals (RYTM) Stock Jumps Nearly 6%: What's Driving the Upbeat Tempo? - Daily Chhattisgarh News

May 29, 2025
pulisher
May 29, 2025

Stifel raises Rhythm Pharma stock target to $94, keeps Buy rating - Investing.com Canada

May 29, 2025
pulisher
May 29, 2025

Rhythm Pharmaceuticals (RYTM) Target Price Boosted by Analyst | - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Rhythm Pharmaceuticals (RYTM) Target Price Boosted by Analyst | RYTM Stock News - GuruFocus

May 29, 2025
pulisher
May 28, 2025

Ameriprise Financial Inc. Purchases 11,480 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

May 28, 2025
pulisher
May 27, 2025

POMC Deficiency Obesity Market on Track for Major Expansion - openPR.com

May 27, 2025
pulisher
May 24, 2025

(RYTM) Investment Analysis - news.stocktradersdaily.com

May 24, 2025
pulisher
May 22, 2025

Deutsche Bank AG Has $2.73 Million Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

May 22, 2025
pulisher
May 21, 2025

Gotham Asset Management LLC Sells 2,685 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

May 21, 2025
pulisher
May 21, 2025

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives $75.38 Consensus Price Target from Analysts - Defense World

May 21, 2025
pulisher
May 14, 2025

Rhythm Pharmaceuticals Announces New Data Presentations on Patie - GuruFocus

May 14, 2025
pulisher
May 14, 2025

(RYTM) On The My Stocks Page - news.stocktradersdaily.com

May 14, 2025
pulisher
May 14, 2025

RYTM Shows Positive Results in Hypothalamic Obesity Treatment | - GuruFocus

May 14, 2025
pulisher
May 14, 2025

RYTM Shows Positive Results in Hypothalamic Obesity Treatment | RYTM Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Rhythm Pharmaceuticals Announces New Data Presentations on Patients with Acquired or Congenital Hypothalamic Obesity (N=35) Treated with Setmelanotide for up to Nine Months in French Early-access Program - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

New Clinical Data: Rhythm's Obesity Drug Achieves 23% Weight Loss in Real-World Study, FDA Filing Coming Q3 - Stock Titan

May 14, 2025
pulisher
May 13, 2025

Raymond James Financial Inc. Buys New Shares in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

May 13, 2025
pulisher
May 12, 2025

Rhythm pharmaceuticals outlines Q3 2025 filing for acquired hypothalamic obesity treatment - MSN

May 12, 2025
pulisher
May 12, 2025

HC Wainwright Has Negative Estimate for RYTM Q2 Earnings - Defense World

May 12, 2025
pulisher
May 09, 2025

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q1 2025 Earnings Call Transcript - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

Rhythm Pharmaceuticals (NASDAQ:RYTM) Trading Down 6.6% on Disappointing Earnings - Defense World

May 09, 2025
pulisher
May 09, 2025

Needham & Company LLC Increases Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $72.00 - Defense World

May 09, 2025
pulisher
May 09, 2025

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 09, 2025
pulisher
May 08, 2025

Rhythm Pharmaceuticals Inc (RYTM) Q1 2025 Earnings Call Highlights: Strong IMCIVREE Sales and ... - Yahoo Finance

May 08, 2025
pulisher
May 07, 2025

Rhythm Pharmaceuticals Q1 2025 slides: Revenue grows 45% as HO program advances - Investing.com Canada

May 07, 2025
pulisher
May 07, 2025

RHYTHM PHARMACEUTICALS, INC. SEC 10-Q Report - TradingView

May 07, 2025
pulisher
May 07, 2025

Rhythm Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (15 Ratings) - Benzinga

May 07, 2025
pulisher
May 07, 2025

Rhythm Pharmaceuticals (RYTM) Price Target Raised by Needham | RYTM Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Rhythm Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat

May 07, 2025
pulisher
May 07, 2025

Earnings call transcript: Rhythm Pharmaceuticals misses Q1 2025 EPS estimates - Investing.com

May 07, 2025

Rhythm Pharmaceuticals Inc (RYTM) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Rhythm Pharmaceuticals Inc (RYTM) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
German Christopher Paul
Corporate Controller & CAO
Jun 10 '25
Sale
67.19
2,069
139,016
1,889
Cramer Pamela J.
Chief Human Resources Officer
Jun 06 '25
Option Exercise
6.80
7,031
47,811
26,240
Cramer Pamela J.
Chief Human Resources Officer
Jun 06 '25
Sale
68.05
7,031
478,435
19,209
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
大文字化:     |  ボリューム (24 時間):